HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Geriatrics17 papers

Gingival disease caused by drug

Last edited: 4/16/2026

Overview

Gingival disease caused by drugs, often referred to as drug-induced gingival enlargement or overgrowth, results from medications that interfere with normal gingival tissue homeostasis, leading to inflammation, hyperplasia, or other oral health complications 1.

Diagnosis

  • Review comprehensive medication list to identify potential offending drugs (e.g., anticonvulsants, immunosuppressants) 1.
  • Clinical examination focusing on gingival swelling, bleeding on probing, and periodontal pocket formation 1.
  • No specific grading system universally recommended; clinical assessment guides management decisions 1.

    • Management

  • Discontinuation or adjustment of the offending drug when possible, under close medical supervision 1.
  • Oral hygiene reinforcement including thorough plaque control and professional dental cleaning 1.
  • Antibacterial therapy with chlorhexidine mouthwash (0.12% solution) for adjunctive treatment 1.
  • Periodontal therapy including scaling and root planing to manage inflammation and pocket depths 1.

    • Special Populations

  • Pregnancy: Management focuses on minimizing drug exposure risks while maintaining oral health; consult obstetrician for drug adjustments 1.
  • Pediatrics: Careful selection of drugs and close monitoring of gingival responses; emphasize preventive oral hygiene practices 1.
  • Elderly: Polypharmacy common; thorough medication review essential to identify and mitigate gingival risks 1.
  • Comorbidities: Tailor management considering interactions between existing conditions and drug-induced gingival disease 1.

    • Key Recommendations

  • Conduct a thorough medication review to identify potential drug-induced gingival risks (Evidence: Strong 1).
  • Implement rigorous oral hygiene practices and consider professional periodontal therapy (Evidence: Moderate 1).
  • Evaluate the feasibility of adjusting or discontinuing the offending drug in consultation with the patient’s primary care provider (Evidence: Expert opinion 1).

    • References

    1 Chávez EM. Systematic review of the medication list: a resource for risk assessment and dental management. Journal of the California Dental Association 2008. link

    Original source

    1. [1]
      Systematic review of the medication list: a resource for risk assessment and dental management. — Chávez EM Journal of the California Dental Association (2008)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG